We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are ... Show More
Sep 11
686. Why Is It So Hard to Find an NFL Quarterback?
For decades, teams have tried (and mostly failed) to predict which college quarterbacks will thrive in the pros. Is the science finally catching up? Stephen Dubner speaks with a scout, a psychologist, a data warrior, and a Hall of Fame quarterback who nobody wanted. SOURCES:Scott ... Show More
58m 20s
Sep 4
685. How to Survive the A.I. Shock
Gina Raimondo, a former commerce secretary and governor, thinks A.I. will create plenty of jobs in the long run. She also thinks a poorly managed transition could tear the country apart. So she came up with a plan. SOURCES:Gina Raimondo, co-chair and C.E.O. of RAISE US. RESOURCES ... Show More
57m 37s
Nov 2020
S3: The Future after COVID-19
Just before our third season starts we talk with Dr Peter Drobac, a global health physician and Director of the Skoll Centre for Social Entrepreneurship, and Dr Aoife Haney, Research Lecturer in Innovation and Enterprise, about the social, economic and environmental changes that ... Show More
41m 58s